In CFS patients, the binding potential values of central 5-HT1A receptors, as well as the levels of serotonin (5-HT) transporters and receptors, are significantly reduced (35, 36). The gene discussed is HTR1A; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.